SS
RLYB icon

SBI Securities’s Rallybio RLYB Stock Holding History

SBI Securities’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.1K Sell
506
-18
-3% -$232 ﹤0.01% 1945
2026
Q1 		$4.7K Sell
524
-7
-1% -$48 ﹤0.01% 2054
2025
Q4 		$2.92K Hold
531
– – ﹤0.01% 2250
2025
Q3 		$2.12K Sell
531
-25
-4% -$105 ﹤0.01% 2396
2025
Q2 		$1.5K Sell
556
-5
-0.9% -$13 ﹤0.01% 2511
2025
Q1 		$2.94K Sell
561
-109
-16% -$689 ﹤0.01% 2129
2024
Q4 		$5.14K Buy
+670
New +$5.61K ﹤0.01% 1912

Other funds holding RLYB

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

SBI Securities's RLYB Position: Q2 2026 in Review

SBI Securities reduced its Rallybio (RLYB) stake by 3.4% in Q2 2026, selling an estimated $232 and leaving 506 shares worth $8.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

SBI Securities first reported a position in RLYB in Q4 2024 and has held it in 7 quarters since. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • SBI Securities held 506 shares of Rallybio worth $8.1K as of Q2 2026.
  • SBI Securities sold 18 Rallybio shares in Q2 2026, an estimated $232.
  • Rallybio made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1945 holding.
  • SBI Securities first reported a position in Rallybio in Q4 2024 and has held it in 7 quarters since.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.